Leveraging AI & Multi-Omic Data to Advance Adaptive Clinical Trials
AI and multi-omic data are redefining adaptive clinical trials by enabling dynamic patient stratification and real-time endpoint modeling, particularly in oncology and stroke. This empowers personalized therapies while maintaining rigorous regulatory oversight and a patient-first focus.
Robert Maxwell
Sep 01, 2025
atrial fibrillation analytics
oncology data integration
stroke trial modeling
adaptive clinical trials
